Literature DB >> 22429367

Aspirin resistance: clinical significance and genetic polymorphism.

Z-H Xu1, J-R Jiao, R Yang, B-Y Luo, X-F Wang, F Wu.   

Abstract

OBJECTIVE: To determine the prevalence, clinical implications and underlying mechanism of aspirin resistance in Chinese patients.
METHODS: Platelet aggregation was determined by light transmission aggregometry (LTA) using four different inducers. Patients were divided into aspirin-resistant (AR), aspirin semi responder (ASR) and aspirin-sensitive (AS) groups, according to their LTA results. Aspirin resistance was assessed by thrombo elastography (TEG, with arachidonic acid [AA] or adenosine diphosphate as inducers), serum/urinary 11-dehydrothromboxane B2 (11-DH-TXB2) assay, platelet function analyser-100 assay and P-selectin assay. Polymorphisms in the prostaglandin endoperoxide synthase 1 (PTGS1) gene (A842G, C50T, C22T, G128A, C644A and C714A), the PTGS2 gene (G765C) and the integrin β3 (ITGB3) gene (C196T) were examined.
RESULTS: The study included 360 aspirin-treated patients and 314 healthy controls. AS patients had significantly lower levels of 11-DH-TXB2 than AR and ASR patients, and significantly lower levels of P-selectin than AR patients. TEG-AA was more sensitive, specific and consistent than P-selectin in detecting aspirin resistance. The frequency of the PTGS2 G765C mutation was significantly higher in the AR/ASR groups versus the AS group.
CONCLUSIONS: TEG-AA was more sensitive, specific and consistent than the P-selectin assay for detecting aspirin resistance, and the PTGS2 G765C mutation may be related to aspirin resistance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22429367     DOI: 10.1177/147323001204000128

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  6 in total

1.  Aspirin as a COX inhibitor and anti-inflammatory drug in human skeletal muscle.

Authors:  Stephen M Ratchford; Kaleen M Lavin; Ryan K Perkins; Bozena Jemiolo; Scott W Trappe; Todd A Trappe
Journal:  J Appl Physiol (1985)       Date:  2017-07-13

2.  Pharmacogenomics Informs Cardiovascular Pharmacotherapy.

Authors:  Mariana Babayeva; Brigitte Azzi; Zvi G Loewy
Journal:  Methods Mol Biol       Date:  2022

3.  Valsartan decreases platelet activity and arterial thrombotic events in elderly patients with hypertension.

Authors:  Fang Wu; Hong-Yan Wang; Fan Cai; Ling-Jie Wang; Feng-Ru Zhang; Xiao-Nan Chen; Qian Yang; Meng-Hui Jiang; Xue-Feng Wang; Wei-Feng Shen
Journal:  Chin Med J (Engl)       Date:  2015-01-20       Impact factor: 2.628

4.  The Effect of Xuefuzhuyu Oral Liquid on Aspirin Resistance and Its Association with rs5911, rs5787, and rs3842788 Gene Polymorphisms.

Authors:  Mei Xue; Lin Yang; Na Kou; Yu Miao; Mingming Wang; Quanli Zhao; Junhua Ren; Shaoyan Zhang; Dazhuo Shi; Keji Chen
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-01       Impact factor: 2.629

5.  Effect of 106PEAR1 and 168PTGS1 genetic polymorphisms on recurrent ischemic stroke in Chinese patient.

Authors:  Jiali Zhao; Fudi Chen; Lin Lu; Hui Tang; Ruirui Yang; Yongxiang Wang; Yifeng Du
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

6.  Prevalence of CYP2C19 and ITGB3 polymorphisms among Bangladeshi patients who underwent percutaneous coronary intervention.

Authors:  Md Rabiul Islam; Tasnova Tasnim Nova; Nam Momenuzzaman; Sikder Nahidul Islam Rabbi; Ishrat Jahan; Thomas Binder; Mohammad Safiqul Islam; Abul Hasnat; Zabun Nahar
Journal:  SAGE Open Med       Date:  2021-08-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.